Marco Bandini1,2,3, Guido Barbagli4,5, Riccardo Leni6, Giuseppe O Cirulli6, Giuseppe Basile6, Sofia Balò5, Francesco Montorsi6, Salvatore Sansalone7, Andrea Salonia6, Alberto Briganti6, Denis Butnaru8, Massimo Lazzeri9. 1. Center for Reconstructive Urethra Surgery, Arezzo, Rome, Milan, Italy. bandini.marco@hsr.it. 2. Centro Chirurgico Toscano, Arezzo, Italy. bandini.marco@hsr.it. 3. Unit of Urology, Urological Research Institute (URI), San Raffaele Hospital, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele Via Olgettina 60, 20132, Milan, Italy. bandini.marco@hsr.it. 4. Center for Reconstructive Urethra Surgery, Arezzo, Rome, Milan, Italy. 5. Centro Chirurgico Toscano, Arezzo, Italy. 6. Unit of Urology, Urological Research Institute (URI), San Raffaele Hospital, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele Via Olgettina 60, 20132, Milan, Italy. 7. Department of Surgical Sciences, University of Tor Vergata, Rome, Italy. 8. Institute for Regenerative Medicine, Sechenov First Moscow State Medical University, Moscow, Russia. 9. Department of Urology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
Abstract
PURPOSE: To conduct a rigorous assessment of in-hospital morbidity after urethroplasty according with the European Association of Urology (EAU) guidelines for complication reporting. METHODS: We retrospectively (2015-2019) identified 469 consecutive patients receiving urethroplasty (e.g. bulbar urethroplasty with grafts, penile urethroplasty with/without grafts/flaps, Johanson, de novo or revision perineostomy, end-to-end anastomosis, meatoplasty and/or meatotomy) at our tertiary care institution. Complications were graded with Clavien-Dindo score and Comprehensive Complication Index (CCI). Complications were classified in: bleeding no gastrointestinal, cardiac, gastrointestinal, genitourinary, infectious, neurological, oral, wound, miscellaneous, and pulmonary. Logistic regression tested for predictors of in-hospital complications and prolonged hospitalization (> 75th percentile). Kaplan-Meier and Cox regression investigated the effect of complications on failure after urethroplasty. RESULTS: Overall, 161 (34.3%) patients experienced at least one complication. Of those, 47 (10%) experienced two or more complications and 59 (12.6%) experienced at least one Clavien-Dindo ≥ II complication. Only two patients had Clavien-Dindo III complications. Infectious was the most frequent complication, and de novo or revision perineostomy was associated with the highest rate of complications. The occurrence of any complications, as well as complication with Clavien-Dindo ≥ II were associated with prolonged hospitalizations, but not with higher rates of post-urethroplasty failure. CONCLUSIONS: Complications after urethroplasty were common events, but rarely with severe sequelae. Infectious were the most common complications and perineostomy was the type of urethroplasty with the highest rate of complications. The application of the EAU recommendations allowed the identifications of a higher number of complications after urethroplasty if compared with previous reports based on unsupervised chart review.
PURPOSE: To conduct a rigorous assessment of in-hospital morbidity after urethroplasty according with the European Association of Urology (EAU) guidelines for complication reporting. METHODS: We retrospectively (2015-2019) identified 469 consecutive patients receiving urethroplasty (e.g. bulbar urethroplasty with grafts, penile urethroplasty with/without grafts/flaps, Johanson, de novo or revision perineostomy, end-to-end anastomosis, meatoplasty and/or meatotomy) at our tertiary care institution. Complications were graded with Clavien-Dindo score and Comprehensive Complication Index (CCI). Complications were classified in: bleeding no gastrointestinal, cardiac, gastrointestinal, genitourinary, infectious, neurological, oral, wound, miscellaneous, and pulmonary. Logistic regression tested for predictors of in-hospital complications and prolonged hospitalization (> 75th percentile). Kaplan-Meier and Cox regression investigated the effect of complications on failure after urethroplasty. RESULTS: Overall, 161 (34.3%) patients experienced at least one complication. Of those, 47 (10%) experienced two or more complications and 59 (12.6%) experienced at least one Clavien-Dindo ≥ II complication. Only two patients had Clavien-Dindo III complications. Infectious was the most frequent complication, and de novo or revision perineostomy was associated with the highest rate of complications. The occurrence of any complications, as well as complication with Clavien-Dindo ≥ II were associated with prolonged hospitalizations, but not with higher rates of post-urethroplasty failure. CONCLUSIONS: Complications after urethroplasty were common events, but rarely with severe sequelae. Infectious were the most common complications and perineostomy was the type of urethroplasty with the highest rate of complications. The application of the EAU recommendations allowed the identifications of a higher number of complications after urethroplasty if compared with previous reports based on unsupervised chart review.
Authors: Sara Jasionowska; Majed Shabbir; Oliver Brunckhorst; Muhammad Shamim Khan; Hussain Manzoor; Prokar Dasgupta; Paul Anderson; Guido Barbagli; Kamran Ahmed Journal: BJU Int Date: 2020-05 Impact factor: 5.588
Authors: Malte W Vetterlein; Jakob Klemm; Philipp Gild; Marlon Bradtke; Armin Soave; Roland Dahlem; Margit Fisch; Michael Rink Journal: Eur Urol Date: 2019-08-29 Impact factor: 20.096
Authors: Giorgio Gandaglia; Carlo Andrea Bravi; Paolo Dell'Oglio; Elio Mazzone; Nicola Fossati; Simone Scuderi; Daniele Robesti; Francesco Barletta; Luca Grillo; Steven Maclennan; James N'Dow; Francesco Montorsi; Alberto Briganti Journal: Eur Urol Date: 2018-03-12 Impact factor: 20.096
Authors: Armin Soave; Roland Dahlem; Hans O Pinnschmidt; Michael Rink; Jessica Langetepe; Oliver Engel; Luis A Kluth; Birte Loechelt; Philip Reiss; Sascha A Ahyai; Margit Fisch Journal: Eur Urol Date: 2017-12-01 Impact factor: 20.096
Authors: Pankaj M Joshi; Marco Bandini; Sandeep Bafna; Vipin Sharma; Amey Patil; Shreyas Bhadranavar; Christian Yepes; Guido Barbagli; Francesco Montorsi; Sanjay B Kulkarni Journal: Eur Urol Open Sci Date: 2021-11-25